TRANSDERM SCOP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Transderm Scop, and what generic alternatives are available?
Transderm Scop is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in TRANSDERM SCOP is scopolamine. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the scopolamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Transderm Scop
A generic version of TRANSDERM SCOP was approved as scopolamine by PADAGIS US on January 30th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRANSDERM SCOP?
- What are the global sales for TRANSDERM SCOP?
- What is Average Wholesale Price for TRANSDERM SCOP?
Summary for TRANSDERM SCOP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Clinical Trials: | 5 |
| Drug Prices: | Drug price information for TRANSDERM SCOP |
| What excipients (inactive ingredients) are in TRANSDERM SCOP? | TRANSDERM SCOP excipients list |
| DailyMed Link: | TRANSDERM SCOP at DailyMed |
Recent Clinical Trials for TRANSDERM SCOP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Repurposed Therapeutics, Inc. | Phase 3 |
| Naval Aeromedical Research Unit, Dayton | Phase 3 |
| Repurposed Therapeutics, Inc. | Phase 2/Phase 3 |
Pharmacology for TRANSDERM SCOP
| Drug Class | Anticholinergic |
| Mechanism of Action | Cholinergic Antagonists |
US Patents and Regulatory Information for TRANSDERM SCOP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | TRANSDERM SCOP | scopolamine | SYSTEM;TRANSDERMAL | 017874-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRANSDERM SCOP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | TRANSDERM SCOP | scopolamine | SYSTEM;TRANSDERMAL | 017874-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Baxter Hlthcare Corp | TRANSDERM SCOP | scopolamine | SYSTEM;TRANSDERMAL | 017874-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Baxter Hlthcare Corp | TRANSDERM SCOP | scopolamine | SYSTEM;TRANSDERMAL | 017874-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
